FDA Approves Xeomin (incobotulinumtoxinA) for Adult Patients with Sialorrhea (Excessive Drooling)
RALEIGH, N.C., July 3, 2018 — Merz North America announced today that the U.S. Food and Drug Administration (FDA) has […]
(incobotulinumtoxinA)
RALEIGH, N.C., July 3, 2018 — Merz North America announced today that the U.S. Food and Drug Administration (FDA) has […](incobotulinumtoxinA)
FDA Approves Xeomin (incobotulinumtoxinA) for Adult Patients with Sialorrhea (Excessive Drooling)
Copyright © 2024